SAUERMANN acquired by VERDER

The management team of Segepo, led by its CEO, becomes the majority shareholder of the group. This capital reorganization, supported by Arkea Capital and Bpifrance, aims to secure the company's independence and finance its "Segepo 2028" strategic plan focusing on modernization and international growth.

Flowserve Corporation has successfully finalized the acquisition of 100% of MOGAS Industries, integrating the entity into its Flow Control Division. This strategic transaction marks a major milestone in the execution of the group's 3D growth strategy, specifically targeting the expansion of its severe service valve portfolio in high-demand sectors such as mining and mineral extraction. The strategic rationale for the acquisition centers on the high degree of complementarity between the target’s specialized metal-seated valve technology and the group’s existing global distribution and aftermarket service scale. By incorporating the target's significant installed base and specialized R&D capabilities, the group reinforces its value proposition as a primary provider of mission-critical flow management for the world's harshest operating environments. The partnership is designed to unlock substantial industrial synergies through procurement optimization and footprint consolidation while accelerating the group’s presence in the lucrative valve repair and maintenance market. This integration consolidates the group’s vision of delivering technically differentiated scale across the global industrial landscape, providing the operational depth required to support large-scale infrastructure modernization and the global energy transition.

IDEX Corporation has successfully completed the acquisition of 100% of Mott Corporation, integrating the entity into its Health & Science Technologies segment. This strategic transaction significantly scales the group's material science suite, providing a massive expansion into the high-value semiconductor and energy transition end markets. The strategic rationale centers on the convergence of the target's sintered porous media expertise with the group's existing precision fluidics and optical capabilities. By incorporating this technical platform, the group bolsters its ability to deliver customized, micro-precision solutions required for customer product performance in harsh environments. The partnership is designed to leverage the group's multidisciplinary technical depth to serve a broader global customer base in medical technology and aerospace. Furthermore, the integration allows for the implementation of the group’s standardized operating model to enhance long-term value creation. This move reinforces the group's standing as a primary enabler of digital and industrial evolution across the most demanding technology verticals.

Ardian has finalized a definitive agreement to sell 100% of its stake in Corob to Graco Inc., marking a strategic exit after a six-year holding period. Under the previous financial sponsorship, the target transitioned from a regional specialist into a global leader by focusing on technical innovation and geographic expansion into high-growth emerging markets. The strategic rationale for the acquisition centers on the acquirer's objective to reinforce its "Contractor" segment and diversify its fluid management portfolio with high-tech automated dispensing systems. By incorporating the target’s specialized R&D capabilities and international service infrastructure, the group establishes a comprehensive platform for the paint and coating distribution market. The partnership is designed to leverage the target’s pioneering expertise in automatic color dosing to offer integrated solutions to a global client base. Furthermore, the integration allows the group to establish its first significant industrial presence in Italy, while capitalizing on the target’s strong operational density in India and Canada. This transaction consolidates the group’s vision of providing end-to-end automated solutions for the chemical and construction sectors.

Investindustrial entered into agreements to acquire a combined 64.82% stake in Piovan (67.96% excluding treasury shares). The transaction involves purchasing 58.35% from Pentafin and 6.47% from 7-Industries. Following the closing, the acquirer will launch a mandatory tender offer to acquire the remaining shares and delist the company from the Milan stock exchange. The partnership is designed to accelerate Piovan's global organic and inorganic growth, with the Piovan family (via Pentafin) reinvesting to maintain a 25% indirect stake in the purchaser. Management continuity is secured, with Nicola Piovan remaining Executive Chairman and Filippo Zuppichin as CEO.

Spectris plc has agreed to acquire 100% of Micromeritics Instrument Corporation. The acquisition, which constitutes a Class 2 transaction under UK Listing Rules, will be funded through existing cash and new external debt. Upon completion, Micromeritics will be integrated with Malvern Panalytical within the Spectris Scientific division. The strategic rationale is to create the global market leader in particle characterisation for advanced materials analysis. By combining Micromeritics’ expertise in surface area and porosity with Malvern Panalytical’s capabilities in size and distribution, Spectris will offer a fully integrated workflow from R&D to QC/QA. The transaction is highly synergistic, with expected run-rate cost synergies of $12 million and significant revenue upside through cross-selling and geographic expansion, particularly in North America and Japan. The deal is expected to be immediately accretive to earnings and margins, supporting Spectris' medium-term objective of 20%+ operating margins.

Spectris has acquired SciAps. SciAps will be integrated into Malvern Panalytical (Spectris Scientific division). The acquisition accelerates Spectris's digital strategy by moving analysis "closer to the sample" (from lab to field). SciAps' handheld XRF and LIBS devices complement Malvern Panalytical's benchtop range, creating a comprehensive suite for customers in mining, recycling, and batteries.

Andera Partners, through its Andera MidCap 5 vehicle, and Equiter have completed the joint acquisition of a 70 percent majority stake in Tecnikabel. The transaction marks Andera’s inaugural deployment within the Italian geography. The founding Garaffi family executed a partial equity rollover to maintain a significant minority interest, ensuring operational continuity and preserving historical customer relationships during the ownership transition. Senior management teams co-invested alongside the financial sponsors to align mid-term operational incentives, while corporate leadership will be altered through the external recruitment of a new Group Chief Executive Officer. Acquisition financing was provided by a domestic banking syndicate including Intesa Sanpaolo, Crédit Agricole, Banco BPM, and Eurizon Capital Real Asset. The post-closing industrial mandate focuses on accelerating inorganic consolidation across European and North American connectivity markets. Capital deployment will prioritize strategic bolt-on acquisitions to capture higher-margin digital and energy transition end-uses. Under this leveraged capital architecture, the sponsors aim to optimize Tecnikabel's operational and financial metrics.

Thermo Fisher Scientific has finalized the acquisition of Olink Holding AB, an operation designed to fundamentally strengthen the group's capabilities in the high-growth proteomics market. The strategic rationale for this transaction centers on a "platform-complementarity" play, merging the target's industry-leading protein analysis technology with the group’s established leadership in mass spectrometry and life sciences instrumentation. This fusion effectively creates a specialized powerhouse in the protein biomarker discovery arena, providing the organization with the necessary technical operational depth to address the increasing demand for precision medicine solutions. This operation allows the group to execute a definitive structural expansion into the high-throughput proteomics sector, specifically targeting the installed base of sequencing systems. By incorporating the target's proprietary PEA technology, the organization can now provide a more robust and integrated solution set for researchers looking to accelerate scientific breakthroughs. The maneuver optimizes the group's financial profile through the realization of significant revenue and cost synergies while leveraging its global commercial machine to drive international market penetration. Ultimately, the partnership solidifies the group’s standing as a primary enabler of proteomic innovation, bridging the gap between sophisticated laboratory-scale diagnostics and industrialized pharmaceutical research standards.

The acquisition of The L.S. Starrett Company by MiddleGround Capital represents a significant take-private transaction in the industrial tools sector, concluding the company's 144-year history as a publicly-traded entity. Strategically, this move allows Starrett to transition from the quarterly pressures of the public markets to a private environment where it can focus on long-term operational flexibility and strategic capital deployment. The rationale for the investment centers on MiddleGround's intent to amplify Starrett's iconic brand status by scaling its geographic reach and diversifying its robust range of metrology and cutting tool offerings. The partnership aims to capitalize on key industrial trends, including the resurgence of advanced manufacturing and the reshoring of critical production to North America. Following the shareholder approval and delisting from the New York Stock Exchange, the company will benefit from MiddleGround’s deep operational expertise and financial backing to professionalize its global manufacturing footprint.